Status
Conditions
Treatments
About
Osteoarthritis is a degenerative disease affecting joint cartilage and its surrounding tissue. It is the leading cause of disability in the elderly. Photobiomodulation (PBM), has been used widely for alleviation of pain, reduction of inflammation, and acceleration of wound healing, and particularly to treat knee osteoarthritis (KOA). The purpose of the current study is to determine if B-Cure laser treatments, applied at home, by the patient or personal caregiver in a real-life situation, can reduce pain and improve functionality in patients with KOA.
Full description
Eligible patients with knee osteoarthritis will receive a B-Cure laser device for self-application at home in addition to standard care. Patients will be invited to the clinic for 3 visits: baseline, 1, and 2 months. Evaluations at the visits will include physical examination, knee range of motion, time up&go test, and patient reported outcomes including subjective pain level by visual analogue scale (VAS), functional and quality of life questionnaires.
The study hypothesis is that B-Cure laser treatments, applied, at home, by the patient, can ameliorate KOA related inflammation thereby reducing pain and improving functionality in these patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Pregnant or nursing, or with the ability to become pregnant and not using an accepted form of birth control
Other causes of knee-related pain (e.g. hip OA, arterial insufficiency, radiculopathy etc) have been ruled out by physical examinations.
Knee surgery for KOA
Intra-articular steroid injection and/or oral steroid treatment within the last six months
Rheumatoid arthritis
Active malignancy
Uncontrolled diabetes mellitus
Neurological conditions: sciatica, neuropathy, multiple sclerosis
Other chronic pain conditions that may affect results: Fibromyalgia, back pain, hip pain
Has any photobiomodulation (low level laser) device at home or has previously used photobiomodulation for knee pain
Has known dermatological sensitivity to light
Enrolled in any other clinical trial within the last 6 weeks or enrollment in another clinical trial during participation in this trial.
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Loading...
Central trial contact
Jehad Khazen, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal